Page 107 - 南京医科大学自然版
P. 107

第44卷第12期         冯   婕,鲍志鹏,周丽华,等. 心房颤动患者射频消融术中首剂肝素ACT预测模型构建[J].
                 2024年12月                    南京医科大学学报(自然科学版),2024,44(12):1715-1722                      ·1721 ·


                这是首个预测房颤消融术首剂肝素 ACT 的预测                                and evolving technologies[J]. Nat Rev Cardiol,2021,18
                模型,也具有一定的准确性和较高的灵敏度,可                                 (3):210-225
                指导房颤患者术中肝素首剂个体化应用的剂量,                            [13]HARADA M,MOTOIKE Y,NOMURA Y,et al. Factors
                以尽早达到目标 ACT,降低房颤导致的致残和致                                associated with silent cerebral events during atrial fibrilla⁃
                                                                       tion ablation in patients on uninterrupted oral anticoagula⁃
                死风险。
                                                                       tion[J]. J Cardiovasc Electrophysiol,2020,31(11):
               [参考文献]                                                  2889-2897
                                                                 [14]MANI H,LINDHOFF⁃LAST E. New oral anticoagulants
               [1] SHI S,TANG Y,ZHAO Q,et al. Prevalence and risk of
                    atrial fibrillation in China:a national cross⁃sectional epi⁃  in patients with nonvalvular atrial fibrillation:a review of
                    demiological study[J]. Lancet Reg Health West Pac,  pharmacokinetics,safety,efficacy,quality of life,and cost
                    2022,23:100439                                     effectiveness[J]. Drug Des Devel Ther,2014,8:789-798
               [2] GELDER I C,RIENSTRA M,BUNTING K V,et al. 2024  [15]VAN GANSE E,DANCHIN N,MAHÉ I,et al. Compara⁃
                    ESC Guidelines for the management of atrial fibrillation  tive safety and effectiveness of oral anticoagulants in non⁃
                                                                       valvular atrial fibrillation:the NAXOS study[J]. Stroke,
                    developed in collaboration with the European Association
                    for Cardio⁃Thoracic Surgery(EACTS)[J]. Eur Heart J,  2020,51(7):2066-2075

                    2024,45(36):3314-3414                        [16]CARNICELLI A P,HONG H,CONNOLLY S J,et al.Di⁃
               [3] LIU Y,LIU Q,YANG Y,et al. Effect of radiofrequency  rect oral anticoagulants versus warfarin in patients with
                    catheter ablation on left atrial structure and function in pa⁃  atrial fibrillation:patient⁃level network meta⁃analyses of
                    tients with different types of atrial fibrillation[J]. Sci  randomized clinical trials with interaction testing by age
                    Rep,2022,12(1):9511                                and sex[J]. Circulation,2022,145(4):242-255
               [4] 王彦涵,张      莱,王    君,等. 心房颤动伴中度及以上心            [17]ZHANG R F,MA C M,WANG N,et al. Appropriate intra⁃
                    房功能性二尖瓣反流患者的临床特征[J]. 南京医科大                         procedural initial heparin dosing in patients undergoing
                    学学报(自然科学版),2024,44(11):1558-1564                   catheter ablation for atrial fibrillation receiving uninter⁃
               [5] 褚    明,丁祥伟,王俊宏,等. 老年房颤患者导管射频消                       rupted non⁃vitamin⁃K antagonist oral anticoagulant treat⁃
                    融疗效及复发相关因素分析[J]. 南京医科大学学报                          ment[J]. BMC Cardiovasc Disord,2021,21(1):214
                   (自然科学版),2020,40(12):1796-1799                 [18]YAMAJI H,MURAKAMI T,HINA K,et al. Adequate ini⁃
               [6] BENALI K,KHAIRY P,HAMMACHE N,et al. Procedure⁃      tial heparin dosage for atrial fibrillation ablation in pa⁃
                    related complications of catheter ablation for atrial fibril⁃  tients receiving non⁃vitamin K antagonist oral anticoagu⁃
                    lation[J]. J Am Coll Cardiol,2023,81(21):2089-2099  lants[J]. Clin Drug Investig,2016,36(10):837-848
               [7] ESCUDERO⁃MARTÍNEZ I,MORALES⁃CABA L,SEGU⁃      [19]DOUKETIS J D,SPYROPOULOS A C,DUNCAN J,et al.
                    RA T. Atrial fibrillation and stroke:a review and new in⁃  Perioperative management of patients with atrial fibrilla⁃
                    sights[J]. Trends Cardiovasc Med,2023,33(1):23-29  tion receiving a direct oral anticoagulant[J]. JAMA In⁃
               [8] CAPPATO R,MARCHLINSKI F E,HOHNLOSER S H,            tern Med,2019,179(11):1469-1478
                    et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin  [20]NAZHA B,PANDYA B,COHEN J,et al. Periprocedural
                    K antagonists for catheter ablation in non⁃valvular atrial  outcomes of direct oral anticoagulants versus warfarin in
                    fibrillation[J]. Eur Heart J,2015,36(28):1805-1811  nonvalvular atrial fibrillation[J]. Circulation,2018,138
               [9] JOGLAR J A,CHUNG M K,ARMBRUSTER A L,et al.         (14):1402-1411
                    2023 ACC/AHA/ACCP/HRS guideline for the diagnosis  [21]WEITZ J I,HEALEY J S,SKANES A C,et al. Periproce⁃
                    and management of atrial fibrillation:a report of the Amer⁃  dural management of new oral anticoagulants in patients
                    ican College of Cardiology/American Heart Association  undergoing atrial fibrillation ablation[J]. Circulation,
                    Joint Committee on Clinical Practice Guidelines[J]. Cir⁃  2014,129(16):1688-1694
                    culation,2024,149(1):e1-e156                 [22]SCHMIDT B,SZÉPLAKI G,MERKELY B,et al. Silent
               [10]BRUNDEL B,AI X,HILLS M T,et al. Atrial fibrilla⁃    cerebral lesions and cognitive function after pulmonary vein
                    tion[J]. Nat Rev Dis Primers,2022,8(1):21          isolation with an irrigated gold⁃tip catheter:REDUCETE
               [11]中华医学会心血管病学分会,中国生物医学工程学会                             pilot study[J]. J Cardiovasc Electrophysiol,2019,30(6):
                    心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心                        877-885
                    血管病杂志,2023,51(6):572⁃618                     [23]BAO W,HU X,GE L,et al. Establishment and validation
               [12]PARAMESWARAN R,AL⁃KAISEY A M,KALMAN J M.            of the nomogram model and the probability of silent cere⁃
                    Catheter ablation for atrial fibrillation:current indications  bral infarction after ablation atrial fibrillation[J/OL]. Car⁃
   102   103   104   105   106   107   108   109   110   111   112